Repligen Corporation Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 23 Posts
1 2
Is It Too Late To Buy Moderna Stock?
Article By: Money Morning Thursday, July 29, 2021 4:34 AM EDT
Moderna Inc. stock skyrocketed last year, moving over 434% on global demand for coronavirus vaccines. The question now is whether it can continue to rally higher, with or without COVID-19.
In this article: RGEN, MRNA Also: JNJ, PFE
Read
Regeneron To Collaborate With Roche For Global Supply Of Its Coronavirus Treatment
Article By: Benzinga Wednesday, August 19, 2020 7:20 AM EDT
Regeneron Pharmaceuticals Inc and Roche Holding AG on Monday disclosed that they are collaborating to develop, manufacture, and distribute the former's COVID-19 antibody cocktail.
In this article: RHHBY, RGEN
Read
Four Stocks To Watch As The Race For A Coronavirus Vaccine Picks Up
Article By: Matt Weller Tuesday, February 25, 2020 11:21 AM EDT
The rapid spread of coronavirus and the potential for global economic disruption led to the worst day for US stocks in two years yesterday.
In this article: JNJ, GILD, RGEN, MRNA Also: ZM
Read
5 Biotech Stocks To Buy Right Now
Article By: Zacks Investment Research Tuesday, June 4, 2019 11:45 AM EDT
The biotech sector has had a rough past few weeks with many stocks hitting their lowest levels since January. That being said, here are five stocks that have outperformed their peers and are expected to have continued growth.
In this article: RGEN, ILMN, GILD, TECH, VRTX
Read
9 Monster Stock Market Predictions For The Week Of January 21
Article By: Michael J. Kramer Monday, January 21, 2019 5:21 AM EDT
It will be a short trading week with Monday closed for Martin Luther King Jr. day. It will also be a relatively light week for economic data in the U.S.. with the Markit Manufacturing and Services PMI’s on Thursday.
In this article: QQQ, XLK, SPX, XLI, XLY, AAPL, MSFT, NFLX, TSLA, MU, ROKU, RGEN
Read
Repligen Sliding After Biggest Customer Launches New Resin
Article By: The Fly Tuesday, September 26, 2017 11:35 AM EDT
Shares of Repligen are sliding after GE Healthcare, its largest customer, announced plans to launch a new Protein A resin that will not use the former as the manufacturer of the associated Protein A ligand.
In this article: GE, RGEN
Read
Update On Currently Recommended Stocks
Article By: SmithOnStocks Monday, September 25, 2017 4:19 PM EDT
In this report I update my objectives and include several buy recommendations in the biotech sphere.
In this article: CYTK, AIS, NWBO, PTLA, RGEN, CYRX, BMY, ALIM, AGEN, EYPT, AMAG, WINT, AMGN, GNE, BIIB
Read
Top Insiders Are Spending Over $1M On These 3 Hot Stocks
Article By: TipRanks Tuesday, September 19, 2017 1:41 PM EDT
Check out the three stocks that are seeing big insider buying from top-ranked insiders right now.
In this article: IFF, RGEN, LVS Also: H, WMT
Read
Repligen Corporation Announces Proposed Public Offering Of Shares Of Common Stock
Article By: NASDAQ GlobeNewswire Tuesday, June 27, 2017 10:02 PM EDT
Repligen Corporation today announced that it has commenced an underwritten public offering of $100,000,000 in shares of its common stock.
In this article: RGEN
Read
Biotechnology Stocks - Repligen Major Breakout
Article By: Taki Tsaklanos Friday, June 23, 2017 5:10 PM EDT
The biotech index is still way below its all-time highs. However, Repligen managed to climb to its highs, which suggests a sector leader.
In this article: RGEN
Read
3 Biotechnology Stocks To Buy On This Biotechnology Breakout
Article By: Taki Tsaklanos Thursday, June 22, 2017 9:11 PM EDT
The biotechnology stock sector is breaking out. After 20 months of consolidation “everyone” forgot about biotechnology stocks, the former leading stock market sector. As it always goes the bull breaks out once all interest is gone.
In this article: RGEN, AMGN, GRFS
Read
Who Are The Next Acquisition Targets In Dermatology?
Article By: Ari Zoldan Wednesday, March 22, 2017 8:25 AM EDT
Specialty pharmaceuticals is a highly dynamic sector with robust stock valuations and an active mergers & acquisition market. One of the most attractive areas for investment is dermatology.
In this article: IMNP, AZN, PFE, SNY, ANAC, RGEN, DERM, FOMX, LBTSF
Read
Bull Of The Day: Repligen
Article By: Kevin Cook Monday, October 19, 2015 1:55 PM EDT
Repligen (RGEN - Snapshot Report) is a $900 million "biotech" company, without the drugs. Repligen supplies R&D and commercial scale recombinant Protein A and affinity chromatography resins to world-class partners and customers.
In this article: RGEN Also: GE, TMO, IBB
Read
Bulls Hold The Line As Market Coils In Anticipation Of A Bigger Move
Article By: Sabrient Systems Monday, May 4, 2015 5:56 PM EDT
After posting record highs the previous week, stocks closed last week slightly down overall. But the major indexes held their psychological levels, including Dow at 18,000, S&P 500 at 2100, NASDAQ at 5,000, and Russell 2000 at 1200.
In this article: SPY, VIX, XLU, IXJ, PXQ, NRG, LVLT, RGEN, HSIC, LOGM
Read
Morning Call For January 12, 2015
Article By: Jim Van Meerten Monday, January 12, 2015 7:59 AM EDT
March E-mini S&Ps (ESH15 +0.55%) this morning are up +0.57% and European stocks are up +1.62% as health-care companies rallied on increased M&A activity and promising drug-test results from Bristol-Myers Squibb.
In this article: AA, BMY, NPSP, DHI, RGEN, SEM, OWW, SWN, MTSN
Read
YTD Review Part 1-FBT Up 49%
Article By: Rod Raynovich Friday, December 12, 2014 3:33 AM EDT
Biotech stocks are following the long term seasonal bullish trend surging in Q4 and up about 49 % YTD. The easiest way to invest in the biotech market is with the ETF First Trust NYSE Arca Biotechnology Index (FBT).
In this article: ALXN, RGEN, SGEN, ALKS, BIIB, CBST, GILD, PCYC, FBT
Read
1 to 16 of 23 Posts
1 2